SARS-CoV-2 infection of human lung ALI cultures reveals basal cells as relevant targets

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets ciliated cells during the initial infection of the upper respiratory tract, although uncertainties persist regarding other involved epithelial cell types. Herein, we utilized viral replication analysis, single-cell RNA sequencing, and spectral microscopy on infected air-liquid interface cultures of human primary nasal and bronchial epithelial cells to discern cell type proportions in relation to SARS-CoV-2 tropism and immune activation. We revealed that, alongside ciliated and secretory cells, SARS-CoV-2 (wildtype and lineage B1.1.7 [Alpha variant]) strongly infects basal cells, significantly contributing to the epithelial immune response in a donor-specific manner. Moreover, local Camostat mesylate treatment was effective on both the basal and apical cell compartment, resulting in a notable reduction in viral load and reduced immune activation. Collectively, our data emphasize the critical role of basal cells in facilitating SARS-CoV-2 dissemination within the upper respiratory tract and their substantial contribution to the epithelial immune response. Furthermore, our results highlight the potential of local application of Camostat mesylate as an effective strategy for early inhibiting SARS-CoV-2 infection and mitigating associated immune activation. We used primary human nasal and bronchial epithelial cells cultured at air-liquid interface (ALI) for infection with SARS-CoV-2 wild type and variant B1.1.7 to investigate viral replication, cellular tropism and related transcriptomic response as well as therapeutic-like treatment using Camostat mesylate. ***Submitters state that raw data unavailable due to patient privacy restrictions***